Hans T. Schambye

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

DMRA

Current role

CEO, Board Member

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Damora Therapeutics, Inc. (DMRA)	M.D., Ph.D. Former President and Chief Executive Officer	$547,521	$678,594	—	$73,677	—	—	$1,299,792
2024	Damora Therapeutics, Inc. (DMRA)	M.D., Ph.D. President and Chief Executive Officer	$526,084	$303,156	$142,000	$258,879	—	$199,431	$1,429,550
2023	Damora Therapeutics, Inc. (DMRA)	M.D., Ph.D. President and Chief Executive Officer	$505,741	$181,600	—	$277,774	—	—	$965,115
2022	Damora Therapeutics, Inc. (DMRA)	M.D., Ph.D. President and Chief Executive Officer	$473,182	$226,953	—	$694,682	—	—	$1,394,817
2021	Damora Therapeutics, Inc. (DMRA)	M.D., Ph.D. President and Chief Executive Officer	$512,214	$222,982	—	$2,211,808	—	—	$2,947,004
2020	Damora Therapeutics, Inc. (DMRA)	M.D., Ph.D. President and Chief Executive Officer	$387,493	$257,489	—	$3,258,557	—	—	$3,903,539
2019	Damora Therapeutics, Inc. (DMRA)	M.D., Ph.D. President and Chief Executive Officer	$360,000	$119,000	—	—	—	—	$479,000

Earnings-call appearances and filed executive appointments or departures, newest first.